We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

41 hedge funds and large institutions have $39.8M invested in BioSpecifics Technologies Corp. in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

11% more funds holding

Funds holding: 37 → 41 (+4)

11% more capital invested

Capital invested by funds: $36M → $39.8M (+$3.81M)

40% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 15

Holders
41
Holders Change
+4
Holders Change %
+10.81%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
9
Reduced
15
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NC
Northpointe Capital
Michigan
+$1.8M
2
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$1M
3
Renaissance Technologies
Renaissance Technologies
New York
+$563K
4
PI
Putnam Investments
Massachusetts
+$457K
5
PAM
Paradigm Asset Management
New York
+$354K

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$7.47M
2
Northern Trust
Northern Trust
Illinois
-$773K
3
AC
Amici Capital
New York
-$620K
4
PP
Paloma Partners
Connecticut
-$333K
5
LMF
LMR Master Fund
Cayman Islands
-$181K
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$236K +$215K +12,111 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$232K +$211K +11,901 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$173K -$5.32K -300 -3%
Deutsche Bank
29
Deutsche Bank
Germany
$130K -$179K -10,120 -60%
BJ
30
BlackRock Japan
Japan
$122K -$103K -5,813 -48%
FNYS
31
First New York Securities
New York
$58K +$53.2K +3,000 New
BIT
32
BlackRock Institutional Trust
California
$47K -$9.36K -528 -18%
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$38K – – –
U
34
UBS
Switzerland
$36K -$57.2K -3,225 -63%
US Bancorp
35
US Bancorp
Minnesota
$36K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$20K +$14.6K +825 +399%
Bank of America
37
Bank of America
North Carolina
$11K -$169K -9,518 -94%
AllianceBernstein
38
AllianceBernstein
Tennessee
$2K +$514 +29 +36%
Citigroup
39
Citigroup
New York
$2K +$1.74K +98 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5 – – –
PP
41
Paloma Partners
Connecticut
– -$333K -21,365 Closed
LMF
42
LMR Master Fund
Cayman Islands
– -$181K -11,594 Closed
Barclays
43
Barclays
United Kingdom
– -$93.7K -5,288 -100%
AIG
44
American International Group
New York
– -$53.3K -3,414 Closed
NFA
45
Nationwide Fund Advisors
Ohio
– -$34K -2,211 Closed
TCIM
46
TIAA CREF Investment Management
New York
– -$7K -462 Closed
1
2

BSTC Hedge Fund Activity: Q3 2013 in Review

41 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2013, worth a combined $39.8M — up 11% from $36M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new BSTC positions and 6 closed out — a net gain of 4 holders — while 9 added to existing stakes and 15 trimmed.

The largest buyer was Northpointe Capital, opening a new position worth an estimated $1.8M. The largest seller was BlackRock Advisors, cutting an estimated $7.47M.

  • 41 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2013, up from 37 in Q2 2013.
  • Funds reported $39.8M of BioSpecifics Technologies Corp. stock for Q3 2013, up 11% quarter-over-quarter.
  • 10 funds opened new BioSpecifics Technologies Corp. positions in Q3 2013 and 6 closed out, a net change of +4 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q3 2013 was Northpointe Capital, an estimated $1.8M added.
  • The largest BioSpecifics Technologies Corp. seller in Q3 2013 was BlackRock Advisors, an estimated $7.47M sold.

Based on aggregated 13F filings for Q3 2013.